These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 24237037)
21. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127 [TBL] [Abstract][Full Text] [Related]
22. Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population. Hindorf U; Peterson C; Almer S Ther Drug Monit; 2004 Dec; 26(6):673-8. PubMed ID: 15570193 [TBL] [Abstract][Full Text] [Related]
23. [Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites]. Alvarez Beltran M; Infante Pina D; Tormo Carnicé R; Segarra Cantón O; Redecillas Ferreiro S An Pediatr (Barc); 2009 Feb; 70(2):126-31. PubMed ID: 19217567 [TBL] [Abstract][Full Text] [Related]
25. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981 [TBL] [Abstract][Full Text] [Related]
26. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587 [TBL] [Abstract][Full Text] [Related]
27. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD. Spencer E; Norris E; Williams C; Dubinsky MC Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603 [TBL] [Abstract][Full Text] [Related]
28. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046 [TBL] [Abstract][Full Text] [Related]
29. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity. Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961 [TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease. Hindorf U; Lindqvist M; Peterson C; Söderkvist P; Ström M; Hjortswang H; Pousette A; Almer S Gut; 2006 Oct; 55(10):1423-31. PubMed ID: 16543290 [TBL] [Abstract][Full Text] [Related]
31. The utility of thiopurine methyltransferase enzyme testing in inflammatory bowel disease. Chisick L; Oleschuk C; Bernstein CN Can J Gastroenterol; 2013 Jan; 27(1):39-43. PubMed ID: 23378982 [TBL] [Abstract][Full Text] [Related]
32. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634 [TBL] [Abstract][Full Text] [Related]
33. Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine. Kaskas BA; Louis E; Hindorf U; Schaeffeler E; Deflandre J; Graepler F; Schmiegelow K; Gregor M; Zanger UM; Eichelbaum M; Schwab M Gut; 2003 Jan; 52(1):140-2. PubMed ID: 12477776 [TBL] [Abstract][Full Text] [Related]
34. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease. Herrlinger KR; Fellermann K; Fischer C; Kreisel W; Deibert P; Schoelmerich J; Fleig WE; Ruhl A; Reinshagen M; Greinwald R; Stange EF; Schwab M Aliment Pharmacol Ther; 2004 Jun; 19(12):1269-76. PubMed ID: 15191508 [TBL] [Abstract][Full Text] [Related]
35. Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn's disease. Wu J; Gao Y; Yang C; Yang X; Li X; Xiao S J Transl Med; 2013 Sep; 11():235. PubMed ID: 24070341 [TBL] [Abstract][Full Text] [Related]
36. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Ardizzone S; Bollani S; Manzionna G; Imbesi V; Colombo E; Bianchi Porro G Dig Liver Dis; 2003 Sep; 35(9):619-27. PubMed ID: 14563183 [TBL] [Abstract][Full Text] [Related]